AGC Biologics Appoints Alberto Santagostino as new Chief Executive Officer
AGC Biologics, headquartered in Seattle, has announced the appointment of Alberto Santagostino to Chief Executive Officer and President.
Santagostino has an extensive background in biotech, pharma, and management of large-scale global CDMO operations, having most recently served as the Head of Cell and Gene Technology at Lonza.
“We will have customers at the heart of our action and our technical talent as the enabler of our CDMO’s aspiration of friendly & expert services to the biopharma industry,” said Santagostino.
Under his leadership, AGC Biologics is poised to further its impressive track record within Seattle’s life sciences hub and beyond.